» Articles » PMID: 11599309

Neuroactive Steroids and Central Nervous System Disorders

Overview
Date 2001 Oct 16
PMID 11599309
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Steroid hormones are vital for the cell life and affect a number of neuroendocrine and behavioral functions. In contrast to their endocrine actions, certain steroids have been shown to rapidly alter brain excitability and to produce behavioral effects within seconds to minutes. In this article we direct attention to this issue of neuroactive steroids by outlining several aspects of current interest in the field of steroid research. Recent advances in the neurobiology of neuroactive are described along with the impact of advances on drug design for central nervous system (CNS) disorders provoked by neuroactive steriods. The theme was selected in association with the clinical aspects and therapeutical potentials of the neuroactive steroids in CNS disorders. A wide range of topics relating to the neuroactive steroids are outlined, including steroid concentrations in the brain, premenstrual syndrome, estrogen and Alzheimer's disease, side effects of oral contraceptives, mental disorder in menopause, hormone replacement therapy, Catamenial epilepsy, and neuractive steroids in epilepsy treatment.

Citing Articles

Steroid profiling in human primary teeth via liquid chromatography-tandem mass spectrometry for long-term retrospective steroid measurement.

Wu R, Hamden J, Salehzadeh M, Li M, Poudel A, Schmidt K PLoS One. 2024; 19(8):e0309478.

PMID: 39197060 PMC: 11357110. DOI: 10.1371/journal.pone.0309478.


Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Atalar A, Baykan B Noro Psikiyatr Ars. 2022; 59(1):68-76.

PMID: 35317501 PMC: 8895800. DOI: 10.29399/npa.27976.


Steroid Sulfation in Neurodegenerative Diseases.

Vitku J, Hill M, Kolatorova L, Kubala Havrdova E, Kancheva R Front Mol Biosci. 2022; 9:839887.

PMID: 35281259 PMC: 8904904. DOI: 10.3389/fmolb.2022.839887.


Epibrassinolide prevents tau hyperphosphorylation via GSK3β inhibition in vitro and improves Caenorhabditis elegans lifespan and motor deficits in combination with roscovitine.

Obakan Yerlikaya P, Arisan E, Coker Gurkan A, Okumus O, Yenigun T, Ozbey U Amino Acids. 2021; 53(9):1373-1389.

PMID: 34386848 DOI: 10.1007/s00726-021-03027-2.


Development and validation of a predictive model of drug-resistant genetic generalized epilepsy.

Choi H, Detyniecki K, Bazil C, Thornton S, Crosta P, Tolba H Neurology. 2020; 95(15):e2150-e2160.

PMID: 32759205 PMC: 7713754. DOI: 10.1212/WNL.0000000000010597.